Gorka Orive ✓

@gorka_orive · Vitoria-Gasteiz, (Spain) · joined 06 Aug 2016

Full Professor of Pharmacy @upvehu | Scientist | Advisor | Entrepreneur | Founder & CSO of Geroa Diagnostics in #Alzheimer (https://t.co/wcI72GUxTD) Tweets are mine

117 585Followers

2 498Following

25 616Posts total

23.2KViews on collected posts

Son gönderiler

Gorka Orive ✓@gorka_orive17 Sep

A principios de septiembre, nuestro grupo de Investigacion BSPB tuvo el placer de recibir en Vitoria-Gasteiz al gran científico @AlistairBoxall, con el objetivo de reforzar la colaboración científica entre nuestros grupos, compartir conocimiento y aprender de su experiencia de 2.8K views · 17 likes · 5 reposts · 1 replies Open on X →

Gorka Orive ✓@gorka_orive14 Sep

El oveporexton, fármaco oral agonista de la orexina, se aprueba para tratar la narcolepsia (incapacidad para regular los ciclos de sueño y vigilia. En un ensayo fase III, entre el 48% y el 69% recuperó la capacidad para no dormirse durante el día. https://t.co/UJQE1FysK1 https://

3.6K views · 25 likes · 9 reposts · 1 replies Open on X →

Gorka Orive ✓@gorka_orive12 Sep

@gorka_orive vaya.... no se podia saber? la lipoproteina es usada para reparar daño.... https://t.co/l9RBmwEimQ 64 views · 0 likes · 0 reposts · 0 replies Open on X →

Gorka Orive ✓@gorka_orive12 Sep

@gorka_orive Y ??????????Por favor , amplía 36 views · 0 likes · 0 reposts · 0 replies Open on X →

Gorka Orive ✓@gorka_orive12 Sep

@gorka_orive Estos tratamientos deberían ser accesibles. 96 views · 2 likes · 0 reposts · 0 replies Open on X →

Gorka Orive ✓@gorka_orive12 Sep

@gorka_orive Que viva el sistema inmune!!! 230 views · 7 likes · 0 reposts · 1 replies Open on X →

Gorka Orive ✓@gorka_orive12 Sep

Novartis anuncia que su ensayo clínico fase III (>8000 participantes) con el medicamento inyectable pelacarsén dirigido a bajar la lipoproteína(a) no resultó eficaz a la hora de reducir los ataques cardíacos ni la muerte cardiovascular (vs placebo). https://t.co/4Ke0b1ZCU4

5.2K views · 81 likes · 29 reposts · 2 replies Open on X →

Gorka Orive ✓@gorka_orive12 Sep

Pacientes que sufren cáncer refractario están viajando a Shanghái (China) a recibir tratamiento con células T modificadas (CAR T) ya que el coste puede ser hasta 3 veces inferior. https://t.co/2aiTBwg4X0 https://t.co/0uWpcDpqfc

5.8K views · 105 likes · 32 reposts · 3 replies Open on X →

Gorka Orive ✓@gorka_orive11 Sep

@sciencenoteasy @EstebanDL El endotelio dañado (sin glicocáliz + disfunción). Al perder el glicocáliz y activarse, expresa VCAM-1, ICAM-1, selectinas y libera quimiocinas (sobre todo MCP-1/CCL2). Eso recluta monocitos circulantes hacia la íntima y ya esta en marcha la aterogenesi 582 views · 1 likes · 0 reposts · 1 replies Open on X →

Gorka Orive ✓@gorka_orive30 Jul

Estoy feliz de anunciar que nuestro proyecto "Basque Sustainable Pharmacy" ha resultado ganador del Premio PRAN 2026 a la mejor iniciativa frente a la resistencia a los antibióticos en el medioambiente. Nuestra iniciativa ha sido galardonada en los V Premios PRAN concedidos por h

4.8K views · 40 likes · 7 reposts · 6 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 10 gönderi, 100K–1M takipçi aralığıyla yan yana. takipçi aralığının tam medyanında.

Medyan görüntülenme1 692bu hesap6 000100K–1M için medyan

Erişim, %1.44%bu hesap1.62%100K–1M için medyan

Etkileşim, %1.04%bu hesap0.98%100K–1M için medyan

Ölçüt	Bu hesap	100K–1M için medyan	Oran
Gönderi başına medyan görüntülenme	1 692	6 000	0.28×
Erişim (görüntülenme ÷ takipçi)	1.44%	1.62%	0.89×
Etkileşim oranı	1.04%	0.98%	1.06×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

4.8K30 Jul

58211 Sep

5.8K12 Sep

5.2K

230

3.6K14 Sep

2.8K17 Sep

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.11%30 Jul

0.52%11 Sep

2.43%12 Sep

2.19%

3.48%

2.08%

0.00%

0.96%14 Sep

0.82%17 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.98%.

What the audience does

Likes69.0%278 in total

Reposts20.3%82 in total

Replies3.7%15 in total

Quotes0.7%3 in total

Bookmarks6.2%25 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar